טוען...
Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc(+/min) mice
Anti-VEGF-A monoclonal antibodies, in combination with chemotherapy, result in a survival benefit in patients with metastatic colorectal and non-small cell lung cancer, but little is known regarding the impact of anti-VEGF-A therapy on benign or premalignant tumors. The Apc(+/min) mice have been wid...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
National Academy of Sciences
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1888576/ https://ncbi.nlm.nih.gov/pubmed/17553957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0704213104 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|